Doctor profile · Federal record
Dr. Betty Rajan, M.D.
Dermatology Physician (CMS: Dermatology) · Fort Worth, TX
- NPI 1396793311
- Accepts Medicare
- MIPS 94.4 / 100 · 2023
- 32 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6600 Bryant Irvin RD
Fort Worth, TX 761324217
(817) 820-0011
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- September 8, 2011
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #J9541
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396793311. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,783
Distinct HCPCS
10
Medicare allowed
$321,749
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 5,201 | 26 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,490 | 282 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,079 | 723 | $90 | |
17000 |
Destruction of precancer skin growth, 1 growth | 558 | 408 | $53 | |
17110 |
Destruction of skin growth, 1-14 growths | 369 | 299 | $114 | |
11102 |
Biopsy of related skin growth, first growth | 350 | 296 | $92 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 210 | 171 | $127 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 168 | 168 | $112 | |
11103 |
Biopsy of related skin growth, each additional growth | 65 | 53 | $51 | |
12031 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | 44 | 38 | $230 |
In context: peer comparison
Among 12 peers in Fort Worth Dermatology Physician, average services per provider: 297. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$3,283
Transactions
139
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 17 | $577.07 | |
| Novartis Pharmaceuticals Corporation | 16 | $431.66 | |
| Genzyme Corporation | 11 | $425.28 | |
| Dermavant Sciences, INC. | 21 | $259.16 | |
| Arcutis Biotherapeutics, INC. | 11 | $230.05 | |
| Regeneron Healthcare Solutions, INC. | 9 | $207.56 | |
| Galderma Laboratories, L.P. | 13 | $153.56 | |
| Janssen Biotech, INC. | 8 | $151.11 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $118.04 | |
| Leo Pharma INC. | 5 | $116.17 | |
| Lilly USA, LLC | 4 | $94.73 | |
| Pfizer INC. | 5 | $92.34 | |
| Amgen INC. | 3 | $86.13 | |
| Mayne Pharma Commercial LLC | 8 | $83.84 | |
| Ucb, INC. | 3 | $63.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
825
Patients
612
Total drug cost
$36,273
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 123 | 105 | $1,063 |
| Doxycycline Hyclate | Generic | 122 | 74 | $4,034 |
| Fluorouracil | Generic | 117 | 109 | $11,753 |
| Clobetasol Propionate | Generic | 111 | 82 | $7,742 |
| Ketoconazole | Generic | 81 | 59 | $1,993 |
| Spironolactone | Generic | 50 | 14 | $1,279 |
| Cephalexin | Generic | 43 | 39 | $432 |
| Hydrocortisone | Generic | 28 | 21 | $552 |
| Metronidazole | Generic | 28 | 22 | $2,454 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 23 | 17 | $510 |
Frequently asked questions
What is Dr. Betty Rajan's medical specialty?
Dr. Betty Rajan practices Dermatology Physician in Fort Worth, TX.
Where does Dr. Betty Rajan practice?
Dr. Betty Rajan practices at 6600 Bryant Irvin RD, Fort Worth, TX 761324217. Office phone: 8178200011.
What is Dr. Betty Rajan's NPI?
Dr. Betty Rajan's National Provider Identifier (NPI) is 1396793311, issued by NPPES.
Does Dr. Betty Rajan accept Medicare assignment?
Yes. Dr. Betty Rajan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Betty Rajan commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.